Mn Services Vermogensbeheer B.V. Has $34.31 Million Stock Holdings in Elevance Health, Inc. (NYSE:ELV)

Mn Services Vermogensbeheer B.V. raised its holdings in Elevance Health, Inc. (NYSE:ELV) by 2.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 93,000 shares of the company’s stock after acquiring an additional 2,300 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in Elevance Health were worth $34,308,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in ELV. Arkadios Wealth Advisors lifted its stake in Elevance Health by 14.4% in the third quarter. Arkadios Wealth Advisors now owns 993 shares of the company’s stock valued at $516,000 after acquiring an additional 125 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Elevance Health by 42.6% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 20,427 shares of the company’s stock worth $10,622,000 after buying an additional 6,098 shares during the last quarter. J.W. Cole Advisors Inc. lifted its stake in shares of Elevance Health by 3.8% in the third quarter. J.W. Cole Advisors Inc. now owns 1,325 shares of the company’s stock worth $689,000 after buying an additional 49 shares during the last quarter. Integrated Advisors Network LLC increased its position in Elevance Health by 3.9% during the third quarter. Integrated Advisors Network LLC now owns 5,942 shares of the company’s stock worth $3,090,000 after acquiring an additional 222 shares during the period. Finally, Diversify Advisory Services LLC increased its position in Elevance Health by 6.2% during the third quarter. Diversify Advisory Services LLC now owns 701 shares of the company’s stock worth $365,000 after acquiring an additional 41 shares during the period. 89.24% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have issued reports on ELV. Argus reissued a “hold” rating and issued a $405.40 price target on shares of Elevance Health in a report on Wednesday, January 29th. Wells Fargo & Company lowered their target price on shares of Elevance Health from $483.00 to $478.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Truist Financial reduced their price target on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald reiterated an “overweight” rating and set a $485.00 price target on shares of Elevance Health in a research report on Friday, January 24th. Finally, Mizuho reduced their target price on shares of Elevance Health from $585.00 to $505.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th. Four analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Elevance Health currently has an average rating of “Moderate Buy” and a consensus target price of $517.03.

Elevance Health Trading Down 3.9 %

Shares of ELV stock opened at $386.22 on Thursday. The stock has a market cap of $87.81 billion, a P/E ratio of 15.08, a price-to-earnings-growth ratio of 1.18 and a beta of 0.83. Elevance Health, Inc. has a 1 year low of $362.21 and a 1 year high of $567.26. The company has a current ratio of 1.45, a quick ratio of 1.50 and a debt-to-equity ratio of 0.71. The stock has a 50 day simple moving average of $386.62 and a 200 day simple moving average of $440.93.

Elevance Health (NYSE:ELV) last released its earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share for the quarter, beating analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%. On average, research analysts predict that Elevance Health, Inc. will post 33.96 earnings per share for the current fiscal year.

Elevance Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be issued a dividend of $1.71 per share. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Monday, March 10th. This is an increase from Elevance Health’s previous quarterly dividend of $1.63. Elevance Health’s dividend payout ratio is 26.71%.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.